Inactive Instrument

DIAGNOSTIC MEDICAL Stock Euronext Paris

Equities

FR0000063224

Advanced Medical Equipment & Technology

End-of-day quote Euronext Paris
- EUR - Intraday chart for DIAGNOSTIC MEDICAL
Sales 2021 39.99M 42.6M Sales 2022 37.06M 39.47M Capitalization 16.28M 17.34M
Net income 2021 -3M -3.2M Net income 2022 -6M -6.39M EV / Sales 2021 0.78 x
Net Debt 2021 11.67M 12.43M Net Debt 2022 10.98M 11.69M EV / Sales 2022 0.74 x
P/E ratio 2021
-5.08 x
P/E ratio 2022
-2.39 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 91.86%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chairman - 11-09-26
Director/Board Member - -
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman - 11-09-26
Director/Board Member - -
Director/Board Member - -
More insiders
Diagnostic Medical Systems (DMS) is France's leader in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: - radiology equipment and osteodensitometers sales (98.1%; DMS Imaging): mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; - development of biotechnology solutions (1.9%; DMS Biotech): in the fields of arthrosis treatment and regenerative medicine. Products and services are marketed primarily by exclusive retailers. Net sales (not including sold divisions) are distributed geographically as follows: Europe (67.7%), Asia (11.9%), Americas (10.6%), Africa (3.6%), Middle East (2.7%), Oceania (1%) and other (2 .5%).
More about the company